Comment
Nicole Farah reflects on how much we’re still learning about the relationship between hormones, the endocannabinoid system (ECS) and cannabis-based medicines.
News
Jodie Yettram ·
Comment
Opinion editor ·
News
Jodie Yettram ·
Journalism built on science, not speculation.
Upcoming Symposiums
Evidence-led education for clinicians, industry and patient advocates — across Europe.
Every ticket includes 12 months’ free MCCS membership — worth up to £120.
4 November 2026
Frankfurt · Mainhaus
26 November 2026
London · Conway Hall
The pharmaceutical industry representative will examine treatment costs and what policy changes mean for patients.
Researchers in Scotland are testing CBD for endometriosis and the lasting effects of chemotherapy, while European back-pain trials have helped bring a cannabis medicine to market. Cannabis Health looks at the studies, their findings and what comes next.
Professor Sylvia Mechsner will examine the evidence for medical cannabis in women’s health on 4 November.
Science & Evidence — Spotlight
We read the studies so you don’t have to — separating robust findings from headlines, with the methods and caveats laid bare.
Explore the research
Plain-language guides to conditions, cannabinoids and what the evidence actually says.
Explore patient guidesRegulatory change, clinical evidence and the patient perspective for prescribers and pharmacists.
Enter the clinical hubWhy clinicians attend the symposiumDirectory
Browse verified UK medical cannabis clinics and pharmacies — online and in person.
Upcoming Symposiums
Evidence-led education for clinicians, industry and patient advocates — across Europe.
Every ticket includes 12 months’ free MCCS membership — worth up to £120.
4 November 2026
Frankfurt · Mainhaus
26 November 2026
London · Conway Hall
